舌与口底鳞癌:从淋巴结转移至肿瘤复发的不同失败模式与临床病理风险特征
这项单中心回顾性研究纳入438例接受手术及颈清扫的舌或口底原发口腔鳞癌患者,随访至少6个月者363例。中位随访期间33.1%出现复发,局部复发与淋巴结外侵犯独立相关,同侧淋巴结复发与淋巴结比率>0.1相关,而对侧淋巴结复发无参数可预测。
要点
- 局部复发独立关联淋巴结外侵犯(HR 1.88)。
- 同侧淋巴结复发关联淋巴结比率>0.1(HR 4.90)。
- 对侧淋巴结复发无评估参数可预测。
核心结论
- 局部复发和同侧淋巴结复发与不同临床病理因素独立相关,而对侧淋巴结复发难以用常规参数预测。
- 淋巴结比率与同侧复发风险及较短无事件生存相关,可作为风险分层监测的潜在标志物。
研究设计与样本
- 回顾性单中心研究,纳入2011-2021年接受手术切除及颈清扫的舌或口底原发口腔鳞癌患者438例。
- 复发模式分析限于随访至少6个月的363例患者,采用多因素Cox回归(校正辅助治疗)和Kaplan-Meier分析。
主要发现
- 随访队列中120例(33.1%)出现复发。
- 局部复发率18.5%,独立关联淋巴结外侵犯(HR 1.88,95%CI 1.04-3.40;p=0.037)。
- 同侧淋巴结复发率11.0%,淋巴结比率>0.1对比淋巴结比率=0的HR为4.90(95%CI 1.76-13.63;p=0.002)。
- 对侧淋巴结复发率8.5%,无任何评估参数可预测。
- 淋巴结比率>0.1者复发中位时间为19.2个月,对比103.0-112.4个月(p<0.001)。
关键数值与推荐
- 局部复发独立风险因素:淋巴结外侵犯(HR 1.88,95%CI 1.04-3.40;p=0.037)。
- 同侧淋巴结复发风险因素:淋巴结比率>0.1对比淋巴结比率=0(HR 4.90,95%CI 1.76-13.63;p=0.002)。
- 淋巴结比率>0.1者复发中位时间19.2个月,淋巴结比率=0者为103.0-112.4个月(p<0.001)。
临床怎么用
- 对淋巴结外侵犯阳性患者应加强局部复发监测。
- 淋巴结比率>0.1提示同侧淋巴结复发风险高且无事件生存短,可考虑风险adapted监测策略。
- 对侧淋巴结复发缺乏有效预测指标,常规参数难以指导针对性监测。
局限性
- 回顾性单中心设计,可能存在选择偏倚。
- 复发模式分析仅限随访至少6个月的患者,可能遗漏早期复发事件。
- 对侧淋巴结复发预测因素未发现,样本量可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Locoregional recurrence remains a clinically relevant problem in oral squamous cell carcinoma (OSCC). Whether local, ipsilateral nodal, and contralateral nodal failure represent distinct disease processes with different clinicopathological associations has not been systematically evaluated. METHODS: This retrospective single-center study included patients only with primary OSCC of the tongue or floor of mouth undergoing surgical resection and neck dissection (2011-2021; n = 438). Oncologic recurrence patterns were evaluated in patients with at least six months of follow-up (n = 363) using multivariable Cox regression adjusted for adjuvant therapy and Kaplan-Meier analyses. RESULTS: Nodal involvement at primary surgery was associated with depth of invasion, bone infiltration, and posterior tongue subsites. In the follow-up cohort, 120 patients (33.1%) developed recurrence. Local recurrence (18.5%) was independently associated with extranodal extension (HR 1.88, 95% CI 1.04-3.40; p = 0.037). Ipsilateral nodal recurrence (11.0%) was associated with lymph node ratio (LNR) > 0.1 versus LNR = 0 (HR 4.90, 95% CI 1.76-13.63; p = 0.002). Contralateral nodal recurrence (8.5%) was not predicted by any evaluated parameter. Patients with LNR > 0.1 experienced recurrence after a median of 19.2 versus 103.0-112.4 months (p < 0.001). CONCLUSION: Local and ipsilateral recurrences showed distinct associations with clinicopathological factors, while contralateral recurrence remained poorly predicted by routine parameters. Lymph node ratio was associated with ipsilateral recurrence risk and shorter event-free survival, supporting its use as a potential stratification marker for risk-adapted surveillance.
引用
- Ketschau J, Mohr J, Grabenhorst A, et al. From Nodal Metastasis to Oncologic Recurrence in Tongue and Oral Floor Squamous Cell Carcinoma: Distinct Failure Patterns and Clinicopathological Risk Profiles. Head Neck. 2026. PMID: 42266014. doi:10.1002/hed.70349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。